MktsMarkets

Ginkgo Bioworks Holdings, Inc.
NYSE: DNAKey statistics
DNA News
Stories mentioning DNA from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 19,474 | 43,484 | 38,837 | 49,604 | 38,230 | 43,847 | 89,046 | 56,206 |
| Cost of Goods Sold | 3,098 | 4,090 | ||||||
| Gross Profit | 16,376 | 34,140 | ||||||
| Operating Expenses | ||||||||
| Research & Development | 49,920 | 50,127 | 69,353 | 53,370 | 70,923 | 76,377 | 77,006 | 134,221 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 104,148 | 128,854 | 115,145 | 137,286 | 147,453 | 144,250 | 279,151 | |
| Operating Income (Loss) | (71,374) | (78,748) | (90,017) | (65,541) | (80,972) | (103,606) | (55,204) | (222,945) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | (4,765) | (10,293) | 9,263 | 4,958 | (2,250) | (4,253) | (1,574) | 5,954 |
| Pretax Income | (76,139) | (89,041) | (80,754) | (60,583) | (83,222) | (107,859) | (56,778) | (216,991) |
| Tax Provision | (80.00) | (643.00) | 1.00 | (283.00) | 88.00 | (325.00) | (375.00) | 190.00 |
| Net Income (Loss) | (82,587) | (80,755) | (90,957) | (56,403) | (217,181) | |||
| Earnings Per Share (Basic) | (1.39) | 0.00 | (1.45) | (1.10) | (1.68) | 0.00 | (1.08) | (4.23) |
| Earnings Per Share (Diluted) | 0.00 | (1.45) | (1.10) | (1.68) | 0.00 | (1.08) | (4.23) | |
| Weighted Average Shares Outstanding (Basic) | 59,563 | 55,458 | 55,634 | 54,859 | 54,242 | 51,895 | 52,241 | 51,370 |
| Weighted Average Shares Outstanding (Diluted) | 55,458 | 55,634 | 54,859 | 54,242 | 51,895 | 52,246 | 51,376 | |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About DNA
Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) is a stock listed on the New York Stock Exchange under the ticker symbol DNA. It last traded at $7.46 (Nov 20, 2026, 4:00 PM ET), down 9.0% on the day. That gives Ginkgo Bioworks a market capitalisation of $483.6M.
Over the past 52 weeks DNA has traded between $5.37 and $18.22.
Revenue for the quarter ended Mar 31, 2026 was $19.5M; a net loss of $82.6M. Revenue was down 49.1% from $38.2M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $19.5M | -$82.6M | -424.1% |
| Dec 31, 2025 | $43.5M | — | — |
| Sep 30, 2025 | $38.8M | -$80.8M | -207.9% |
| Jun 30, 2025 | $49.6M | — | — |
From Ginkgo Bioworks’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…